Table 1 Correlation between IGF2BP3 expression and clinical characteristics of patients with HCC.
Clinical characteristic | IGF2BP3High (n) | IGF2BP3Low (n) | P-value |
|---|---|---|---|
Age (years) | 0.847 | ||
  < 60 | 34 | 38 |  |
  ≥ 60 | 14 | 17 |  |
Sex | 0.578 | ||
 Men | 43 | 43 |  |
 Women | 10 | 13 |  |
Tumor size (cm) | 0.251 | ||
  < 5 | 23 | 32 |  |
  ≥ 5 | 23 | 20 |  |
Tumor number | 0.468 | ||
 Single | 42 | 47 |  |
 Multiple | 7 | 5 |  |
TNM stage | 0.028* | ||
 I–II | 34 | 44 |  |
 III–IV | 13 | 5 |  |
Microvascular invasion | 0.315 | ||
 No | 27 | 35 |  |
 Yes | 22 | 19 |  |
Liver capsule invasion | 0.022* | ||
 No | 26 | 40 |  |
 Yes | 16 | 8 |  |
Lymphoid infiltrates | 0.067 | ||
 No | 26 | 33 |  |
 Yes | 5 | 1 |  |
Cirrhosis | 0.451 | ||
 No | 7 | 10 |  |
 Yes | 43 | 41 |  |
HBsAg | 0.565 | ||
 No | 6 | 8 |  |
 Yes | 45 | 43 |  |
AFP levels | 0.032* | ||
  < 200 ng/mL | 22 | 31 |  |
  ≥ 200 ng/mL | 29 | 17 |  |
Distant metastases | 0.394 | ||
 No | 44 | 50 |  |
 Yes | 5 | 3 |  |
Lymphatic metastasis | 0.583 | ||
 No | 46 | 51 |  |
 Yes | 3 | 2 |  |
